NASA’s twin Voyager spacecraft have revealed surprising truths about the farthest reaches of our solar system. Nearly 15 ...
CAMBRIDGE, United Kingdom and LEXINGTON, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Transition Bio, a drug discovery company ...
Live Science on MSN
Looking Beyond Voyager 1 And 2
NASA has explored the space beyond Earth and our solar system with spacecraft like Voyagers 1 and 2, and how we’ve discovered ...
In this episode, Ray kicks things off with NASA’s Voyager mission uncovering extreme plasma temperatures—up to 50,000 ...
Imagine a fiery wall of gas reaching temperatures up to 50,000 K (equivalent to 90,000 °F). Thankfully, this barrier is not located near a star or at the ...
Voyager is paying travel partner Transition Bio a single-digit million-dollar upfront payment, with additional payments up to ...
Voyager Technologies, Inc. ("Voyager") (NYSE: VOYG) today announced its intention to offer, subject to market and other conditions, $300 million aggregate principal amount of convertible senior notes ...
Voyager Therapeutics, Inc. (NASDAQ: VYGR) began Monday virtually unchanged The Lexington, Mass.- concern, a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today ...
Voyager Technologies, Inc. ("Voyager") (NYSE: VOYG) today announced the pricing of its offering of $435,000,000 aggregate principal amount of 0.75% convertible senior notes due 2030 (the "notes") in a ...
Collaboration Revenues: Voyager had collaboration revenue of $13.4 million for the third quarter of 2025, compared to $24.6 million for the same period in 2024. The decrease was primarily due to ...
Voyager Technologies upsizes its convertible notes offering to $435M, raising funds for share buybacks and growth.
VOYG] ("Voyager" or the "Company"), today announced financial results for the third quarter 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback